ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,332,000 | -56.7% | 114,500 | -64.5% | 0.82% | -34.8% |
| Q1 2019 | $3,078,000 | +526.9% | 322,600 | +836.3% | 1.26% | +225.5% |
| Q3 2018 | $491,000 | -55.7% | 34,456 | -62.7% | 0.39% | +27.6% |
| Q2 2018 | $1,109,000 | +123.6% | 92,400 | +129.9% | 0.30% | +340.6% |
| Q1 2018 | $496,000 | -75.6% | 40,200 | -71.2% | 0.07% | -71.7% |
| Q4 2017 | $2,030,000 | -19.3% | 139,500 | -21.1% | 0.24% | -11.3% |
| Q3 2017 | $2,516,000 | +39.8% | 176,800 | +25.3% | 0.28% | +25.6% |
| Q2 2017 | $1,800,000 | -7.5% | 141,100 | -8.0% | 0.22% | -8.8% |
| Q1 2017 | $1,945,000 | +128.8% | 153,400 | +84.2% | 0.24% | +58.9% |
| Q4 2016 | $850,000 | -33.2% | 83,300 | -13.8% | 0.15% | -49.5% |
| Q3 2016 | $1,272,000 | -52.9% | 96,600 | -54.6% | 0.30% | -55.8% |
| Q2 2016 | $2,703,000 | +52.7% | 212,800 | +58.8% | 0.68% | +18.4% |
| Q1 2016 | $1,770,000 | +114.3% | 134,000 | +149.5% | 0.57% | +14.9% |
| Q4 2015 | $826,000 | – | 53,700 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |